The University Hospital of North Tees is a general hospital in Stockton-on-Tees, England which provides healthcare to people living in the south east of County Durham. It is managed by the North Tees and Hartlepool NHS Foundation Trust.

There are 563 beds in University Hospital Of North Tees.

During the past decade, University Hospital Of North Tees conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Of North Tees" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 3 trials, followed by "Ottawa Hospital Research Institute" with 2 trials sponsored, "University of Oxford" with 2 trials sponsored, "Air Liquide Santé International" with 1 trials sponsored and "Arthrex, Inc." with 1 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Of North Tees" #1 collaborator was "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator and "Borstkanker Onderzoek Groep" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Of North Tees" are "Breast Cancer" (4 trials), "Asthma" (2 trials), "Metastatic Cancer" (2 trials), "Acute Coronary Syndromes" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "University Hospital Of North Tees" in a lesser frequency.

Most popular intervention types in "University Hospital Of North Tees" are "Drug" (15 trials), "Procedure" (5 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "radiation therapy" (2 trials), "5-fluorouracil" (1 trials), "ARB + DMX-200" (1 trials) and "Acenocoumarol" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Of North Tees" are 20 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital Of North Tees". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in University Hospital Of North Tees, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Of North Tees, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".